Stay updated on Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T12:26:44.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces updates and FAQs about agencies using “Super Intelligence” in place of “Artificial Intelligence” during a transition.
    Difference
    1%
    Check dated 2026-10-26T11:45:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T12:51:15.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:24.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The study record page has been replaced by a 403 Forbidden message with a link back to Home, so study details are not displayed.
    Difference
    0.5%
    Check dated 2026-10-05T14:05:44.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen instead of the study content. Access to the trial's details, eligibility criteria, and related documents is blocked.
    Difference
    17%
    Check dated 2026-09-21T22:14:14.000Z thumbnail image

Stay in the know with updates to Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance Retreatment in Ovarian Cancer Clinical Trial page.